← Evidence map

ReviewJournal of molecular medicine (Berlin, Germany)2016

miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.

Merve Mutlu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

87 papers cite itlatest 60 shown

2016
…
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27094812